General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
Innovative technological advancements drive growth in the neuromodulation market. Extended battery lifespans, directional leads and higher frequency stimulation have all been incorporated in recent years. Regulatory issues may limit growth in the intrathecal pump market over the next years as two leading competitors face challenges. Flowonix had the CE mark for its pump suspended in 2016. Medtronic faces an FDA consent decree and regulators in the U.K. recently published a report on specific issues with device functioning. A major emerging trend in the neurological market is the growth of mechanical thrombectomy devices for ischemic stroke. These devices extend the window for treatment of patients compared to medical therapy alone and can provide dramatically improved clinical outcomes.
'
TABLE OF CONTENTS I
LIST OF FIGURES IX
LIST OF CHARTS XI
EXECUTIVE SUMMARY 1
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
MARKETS INCLUDED 11
PROCEDURES INCLUDED 12
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 Introduction 28
2.2.2 General Diagnostics and Neurosurgery 30
2.2.3 Tumor and Brain Cancer 32
2.2.4 Brain Arteriovenous Malformations 34
2.2.5 Ischemic Stroke 35
2.2.6 Brain Aneurysm 36
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 38
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 38
2.2.7.2 Cerebral Edema 39
2.2.8 Indication for Neuromodulation 41
2.2.9 Traumatic brain injury 43
COUNTRY PROFILES 44
3.1 INTRODUCTION 44
3.1.1 Population 44
3.1.2 GDP Per Capita 44
3.1.3 Price Index 44
3.2 GERMANY 45
3.3 FRANCE 46
3.4 UNITED KINGDOM 47
3.5 ITALY 48
3.6 SPAIN 49
3.7 BENELUX 50
3.8 SCANDINAVIA 51
3.9 AUSTRIA 52
3.10 SWITZERLAND 53
3.11 PORTUGAL 54
PROCEDURE NUMBERS 55
4.1 PROCEDURE ANALYSIS AND FORECAST 55
4.1.1 Total Neurological Device Procedures 55
4.1.2 Cerebrospinal Fluid Shunting Procedures 57
4.1.3 Neurovascular Embolization Procedures 60
4.1.3.1 Detachable Coil Procedures 62
4.1.3.2 Liquid Embolics Procedures 64
4.1.4 Intracranial Stenting Procedures 65
4.1.5 Neurovascular Guidewire Procedures 68
4.1.6 Neuromodulation Procedures 71
4.1.6.1 Spinal Cord Stimulator Implantation Procedures 73
4.1.6.2 Vagus Nerve Stimulator Implantation Procedures 75
4.1.6.3 Deep Brain Stimulator Implantation Procedures 77
4.1.6.4 Sacral Nerve Stimulator Implantation Procedures 79
4.1.6.5 Gastric Electric Stimulator Implantation Procedures 81
ABBREVIATIONS 82
APPENDIX: COMPANY PRESS RELEASES 85
Chart 1 1: Neurological Device Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Neurological Device Market Overview, Europe, 2013 &2023 2
Chart 3 1: Country Profile, Germany, 2016 45
Chart 3 2: Country Profile, France, 2016 46
Chart 3 3: Country Profile, United Kingdom, 2016 47
Chart 3 4: Country Profile, Italy, 2016 48
Chart 3 5: Country Profile, Spain, 2016 49
Chart 3 6: Country Profile, Benelux, 2016 50
Chart 3 7: Country Profile, Scandinavia, 2016 51
Chart 3 8: Country Profile, Austria, 2016 52
Chart 3 9: Country Profile, Switzerland, 2016 53
Chart 3 10: Country Profile, Portugal, 2016 54
Chart 4 1: Neurological Device Procedures by Segment, Europe, 2013 – 2023 56
Chart 4 2: Cerebrospinal Fluid Shunting Procedures, Europe, 2013 – 2023 59
Chart 4 3: Neurovascular Embolization Procedures by Segment, Europe, 2013 – 2023 61
Chart 4 4: Detachable Coil Procedures, Europe, 2013 – 2023 63
Chart 4 5: Liquid Embolics Procedures, Europe, 2013 – 2023 64
Chart 4 6: Intracranial Stenting Procedures, Europe, 2013 – 2023 67
Chart 4 7: Neurovascular Guidewire Procedures, Europe, 2013 – 2023 70
Chart 4 8: Neuromodulation Implantation Procedures by Segment, Europe, 2013 – 2023 72
Chart 4 9: Spinal Cord Stimulator Implantation Procedures, Europe, 2013 – 2023 74
Chart 4 10: Vagus Nerve Stimulator Implantation Procedures, Europe, 2013 – 2023 76
Chart 4 11: Deep Brain Stimulator Implantation Procedures, Europe, 2013 – 2023 78
Chart 4 12: Sacral Nerve Stimulator Implantation Procedures, Europe, 2013 – 2023 80
Chart 4 13: Gastric Electric Stimulator Implantation Procedures, Europe, 2013 – 2023 81
Figure 1 1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3) 4
Figure 1 2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3) 4
Figure 1 3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2016 6
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in the Neurological Device Market, Europe, 2014 – 2016 10
Figure 1 9: Neurological Device Markets Covered, Europe, 2016 11
Figure 1 10: Neurological Device Procedures Covered, Europe, 2016 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Neurology Disease Overview 29
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016 33
Figure 4 1: Neurological Device Procedures by Segment, Europe, 2013 – 2023 55
Figure 4 2: Cerebrospinal Fluid Shunting Procedures by Country, Europe, 2013 – 2023 58
Figure 4 3: Neurovascular Embolization Procedures by Segment, Europe, 2013 – 2023 60
Figure 4 4: Detachable Coil Procedures by Country, Europe, 2013 – 2023 62
Figure 4 5: Liquid Embolics Procedures, Europe, 2013 – 2023 64
Figure 4 6: Intracranial Stenting Procedures by Country, Europe, 2013 – 2023 66
Figure 4 7: Neurovascular Guidewire Procedures by Country, Europe, 2013 – 2023 69
Figure 4 8: Neuromodulation Implantation Procedures by Segment, Europe, 2013 – 2023 71
Figure 4 9: Spinal Cord Stimulator Implantation Procedures by Country, Europe, 2013 – 2023 73
Figure 4 10: Vagus Nerve Stimulator Implantation Procedures by Country, Europe, 2013 – 2023 75
Figure 4 11: Deep Brain Stimulator Implantation Procedures by Country, Europe, 2013 – 2023 77
Figure 4 12: Sacral Nerve Stimulator Implantation Procedures by Country, Europe, 2013 – 2023 79
Figure 4 13: Gastric Electric Stimulator Implantation Procedures, Europe, 2013 – 2023 81
Figure 6 1: Press Release Summary 85
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
